Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of two-dose oral live attenuated human rotavirus vaccine in healthy infants
2015-001541-92Phase 3
- Sponsor
- GSK
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rotaviral diarrhea comparing HRV vaccine with Placebo (2 arms). Primary endpoint: Occurrence of severe rotavirus gastroenteritis caused by wild rotavirus strains.
02
Drugs
rotavirus vaccine, live, attenuated
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on 2015-001541-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001541-92.